Wu Y - Search Results

1

Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer.

Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL, Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, Chang YC, Wang MY, Li CW, Shen J, Chen MK, Sahin AA, Sood A, Mills GB, Yu D, Hortobagyi GN, Hung MC. Hsu YH, et al. Among authors: wu y, wu tj. Cancer Res. 2014 Sep 1;74(17):4822-35. doi: 10.1158/0008-5472.CAN-14-0584. Epub 2014 Jun 26. Cancer Res. 2014. PMID: 24970481 Free PMC article.

2

Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354.

Hawk N, Sun T, Xie S, Wang Y, Wu Y, Liu J, Arlinghaus RB. Hawk N, et al. Among authors: wu y. Cancer Res. 2002 Jan 15;62(2):386-90. Cancer Res. 2002. PMID: 11809685

3

Reproducibility of gene expression signature-based predictions in replicate experiments.

Anderson K, Hess KR, Kapoor M, Tirrell S, Courtemanche J, Wang B, Wu Y, Gong Y, Hortobagyi GN, Symmans WF, Pusztai L. Anderson K, et al. Among authors: wu y. Clin Cancer Res. 2006 Mar 15;12(6):1721-7. doi: 10.1158/1078-0432.CCR-05-1539. Clin Cancer Res. 2006. PMID: 16551855

4

Profile of Ets gene expression in human breast carcinoma.

He J, Pan Y, Hu J, Albarracin C, Wu Y, Dai JL. He J, et al. Among authors: wu y. Cancer Biol Ther. 2007 Jan;6(1):76-82. doi: 10.4161/cbt.6.1.3551. Cancer Biol Ther. 2007. PMID: 17172821 Free article.

5

Loss of annexin A1 expression in breast cancer progression.

Cao Y, Li Y, Edelweiss M, Arun B, Rosen D, Resetkova E, Wu Y, Liu J, Sahin A, Albarracin CT. Cao Y, et al. Among authors: wu y. Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):530-4. doi: 10.1097/PAI.0b013e31817432c3. Appl Immunohistochem Mol Morphol. 2008. PMID: 18776816

6

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.

Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, Wu Y, Arlinghaus RB. Leng X, et al. Among authors: wu y. Cancer Res. 2009 Nov 15;69(22):8579-84. doi: 10.1158/0008-5472.CAN-09-1934. Epub 2009 Nov 3. Cancer Res. 2009. PMID: 19887608

7

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.

Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM. Mittendorf EA, et al. Among authors: wu y. Clin Cancer Res. 2009 Dec 1;15(23):7381-8. doi: 10.1158/1078-0432.CCR-09-1735. Epub 2009 Nov 17. Clin Cancer Res. 2009. PMID: 19920100 Free PMC article.

8

Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma.

Huo L, Bell D, Qiu H, Sahin A, Wu Y, Sneige N. Huo L, et al. Among authors: wu y. Ann Diagn Pathol. 2011 Apr;15(2):84-92. doi: 10.1016/j.anndiagpath.2010.08.007. Epub 2010 Dec 16. Ann Diagn Pathol. 2011. PMID: 21163678

9

Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.

Zhao Y, Liu H, Liu Z, Ding Y, Ledoux SP, Wilson GL, Voellmy R, Lin Y, Lin W, Nahta R, Liu B, Fodstad O, Chen J, Wu Y, Price JE, Tan M. Zhao Y, et al. Among authors: wu y. Cancer Res. 2011 Jul 1;71(13):4585-97. doi: 10.1158/0008-5472.CAN-11-0127. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498634 Free PMC article.

10

Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.

Chen JQ, Bao Y, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Katz RL, Sahin A, Bondy M, Murray JL, Radvanyi L. Chen JQ, et al. Among authors: wu y, wu s. Horm Cancer. 2011 Apr;2(2):132-43. doi: 10.1007/s12672-011-0067-5. Horm Cancer. 2011. PMID: 21761336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,731 results

Search Page

Filters